Skip to the page

Data / Crowdfunding / New York / Sen-Jam Pharmaceutical Inc

Sen-Jam Pharmaceutical Inc: crowdfunding raise on Wefunder Portal LLC, $50,000 to $3,319,224 (2025)

Sen-Jam Pharmaceutical Inc, a corporation in Huntington, NY, filed a Form C with the SEC on June 20, 2025 to raise $50,000 to $3,319,224 in Convertible Note through Wefunder Portal LLC. The offering closed on April 30, 2026. In its most recent fiscal year it reported $0 in revenue and a net loss of $4,475,577, with 5 employees.

SpecStream is the live web data engine for teams and agents. It reads every Form C on SEC EDGAR each morning, and this page is that reading. Ask for your own cut (a portal, a state, a size, a revenue range) and new raises arrive in your sheet, CRM, Slack or agent as they land.

Website
sen-jam.com
Funding portal
Wefunder Portal LLC
Address
223 Wall Street, #130, Huntington, NY 11743
Legal form
Corporation
Jurisdiction
DE
Incorporated
August 21, 2017
SEC CIK
0001802249

Offering terms

From the offering filed June 20, 2025.

Security
Convertible Note
Price
$1.00
Target
$50,000
Maximum
$3,319,224
Deadline
April 30, 2026
Portal compensation
<p>6.5% of the offering amount upon a successful fundraise, and be entitled to reimbursement for out-of-pocket third party expenses it pays or incurs on behalf of the Issuer in connection with the offering.</p>

Financials

From the Form C filed June 20, 2025.

Most recent fiscal yearPrior fiscal yearSource
Revenue$0$0sec.gov
Cost of goods sold$0$0sec.gov
Net income$-4,475,577$-4,355,706sec.gov
Taxes paid$0$0sec.gov
Total assets$1,294,445$950,081sec.gov
Cash$579,282$331,764sec.gov
Accounts receivable$0$0sec.gov
Short-term debt$2,762,742$1,111,512sec.gov
Long-term debt$2,239,984$1,756,114sec.gov

Filings

FiledFilingTargetMaximumDeadlineNoteSource
June 20, 2025Offering$50,000$3,319,224April 30, 2026sec.gov
April 24, 2025Annual reportNot listedNot listedsec.gov
October 3, 2024Amendment$150,000$5,000,000April 30, 2025Changing early bird threshold from $2,500,000 to $1,125,000.sec.gov
April 29, 2024Amendment$150,000$5,000,000April 30, 2025Adding 2023 statements, extending the close date, updating the terms, updating prior raisessec.gov
April 26, 2024Annual reportNot listedNot listedsec.gov
November 20, 2023Amendment$150,000$3,000,000April 29, 2024Updated Early Bird threshold from $500,000 to $600,000. Added parameters for VIP investors to receive preferential terms.sec.gov
October 13, 2023Amendment$150,000$3,000,000April 29, 2024Increasing the Early Bird threshold to $500,000sec.gov
June 2, 2023Offering$150,000$3,000,000April 29, 2024sec.gov
April 14, 2023Annual reportNot listedNot listedsec.gov
January 13, 2023Progress update$9,996$3,992,791January 11, 2023At the close of the offering, the issuer closed on $57,221.74 and 9,157 number of securities.sec.gov
October 21, 2022Amendment$9,996$3,992,791January 11, 2023Issuer is decreasing minimum investment amountsec.gov
October 13, 2022Offering$9,996$1,007,192January 11, 2023sec.gov
October 6, 2022Progress update$50,000$1,070,000June 30, 2022At the close of the offering, the issuer closed on $1,007,201.00.sec.gov
April 29, 2022Amendment$50,000$1,070,000June 30, 2022Extending the closing date and updating the financials.sec.gov
January 24, 2022Amendment$50,000$1,070,000April 30, 2022Adding change of control clause.sec.gov
December 2, 2021Offering$50,000$1,070,000April 30, 2022sec.gov

All filings on sec.gov

Also on SpecStream

Updated June 20, 2025. Read from SEC EDGAR. Public domain (U.S. government work). Financials are as each company reported them in its Form C, unaudited unless the filing says otherwise. Websites are the ones the companies declared to the SEC. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.